Related Experiment Videos
Giant cell arteritis in the ocular ischemic syndrome
L M Hamed1, J R Guy, M L Moster
1Department of Ophthalmology, University of Florida College of Medicine, Gainesville 32610-0284.
American Journal of Ophthalmology
|June 15, 1992
Summary
Giant cell arteritis can cause rare eye problems like oculomotor nerve paresis and ocular ischemic syndrome. Early corticosteroid treatment can resolve these symptoms, highlighting the importance of considering this condition in diagnosis.
Area of Science:
- Ophthalmology
- Rheumatology
- Vascular Neurology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis primarily affecting medium and large arteries.
- Ocular manifestations of GCA are common, but specific syndromes like ocular ischemic syndrome are less frequently reported.
- This study investigates uncommon presentations of GCA involving ocular structures.
Observation:
- Four patients presented with oculomotor nerve paresis, ocular hypotony, and anterior segment ischemia.
- These symptoms were indicative of the ocular ischemic syndrome.
- Temporal artery biopsy confirmed giant cell arteritis in all four patients.
Findings:
- Cerebral angiography/ultrasonography ruled out internal carotid artery stenosis and cerebral aneurysms as causes.
- Corticosteroid therapy was initiated in three patients.
- Treatment led to resolution of oculomotor deficits and ocular ischemic signs, with significant visual acuity improvement in one case.
Implications:
- Giant cell arteritis should be included in the differential diagnosis for patients presenting with the ocular ischemic syndrome.
- Prompt diagnosis and treatment with corticosteroids are crucial for managing GCA-related ocular complications.
- This underscores the importance of a multidisciplinary approach in diagnosing and treating GCA.